These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Moyamoya Disease and Spectrums of RNF213 Vasculopathy. Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369 [TBL] [Abstract][Full Text] [Related]
3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847 [TBL] [Abstract][Full Text] [Related]
4. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593 [TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275 [No Abstract] [Full Text] [Related]
6. A case of hemichorea in RNF213-related vasculopathy. Hosoki S; Yoshimoto T; Ihara M BMC Neurol; 2021 Jan; 21(1):32. PubMed ID: 33482763 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205 [TBL] [Abstract][Full Text] [Related]
8. Role of the Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381 [TBL] [Abstract][Full Text] [Related]
9. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis. Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070 [TBL] [Abstract][Full Text] [Related]
10. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Liao X; Deng J; Dai W; Zhang T; Yan J Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161 [TBL] [Abstract][Full Text] [Related]
11. Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213. Inoue T; Murakami N; Sakadume S; Kido Y; Kikuchi A; Ichinoi N; Suzuki K; Kure S; Sakuta R Pediatr Int; 2015 Aug; 57(4):798-801. PubMed ID: 26315205 [TBL] [Abstract][Full Text] [Related]
12. A new horizon of moyamoya disease and associated health risks explored through RNF213. Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949 [TBL] [Abstract][Full Text] [Related]
13. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. Raso A; Biassoni R; Mascelli S; Nozza P; Ugolotti E; Di Marco E; De Marco P; Merello E; Cama A; Pavanello M; Capra V J Neurosurg Sci; 2020 Apr; 64(2):165-172. PubMed ID: 27787485 [TBL] [Abstract][Full Text] [Related]
14. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. Kamada F; Aoki Y; Narisawa A; Abe Y; Komatsuzaki S; Kikuchi A; Kanno J; Niihori T; Ono M; Ishii N; Owada Y; Fujimura M; Mashimo Y; Suzuki Y; Hata A; Tsuchiya S; Tominaga T; Matsubara Y; Kure S J Hum Genet; 2011 Jan; 56(1):34-40. PubMed ID: 21048783 [TBL] [Abstract][Full Text] [Related]
15. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature. Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898 [TBL] [Abstract][Full Text] [Related]
16. RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557 [TBL] [Abstract][Full Text] [Related]
17. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report. Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577 [TBL] [Abstract][Full Text] [Related]
18. [Precision Medicine for Moyamoya Disease]. Fujimura M No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101 [TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population. Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136 [TBL] [Abstract][Full Text] [Related]
20. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease. Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]